Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

miR-367 promotes proliferation and stem-like traits in medulloblastoma cells

Full text
Author(s):
Kaid, Carolini [1] ; Silva, Patricia B. G. [1] ; Cortez, Beatriz A. [1] ; Rodini, Carolina O. [1] ; Semedo-Kuriki, Patricia [1] ; Okamoto, Oswaldo K. [1]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, Biosci Inst, Human Genome & Stem Cell Res Ctr, Dept Genet & Evolutionary Biol, BR-05508090 Sao Paulo, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: Cancer Science; v. 106, n. 9, p. 1188-1195, SEP 2015.
Web of Science Citations: 23
Abstract

In medulloblastoma, abnormal expression of pluripotency factors such as LIN28 and OCT4 has been correlated with poor patient survival. The miR-302/367 cluster has also been shown to control self-renewal and pluripotency in human embryonic stem cells and induced pluripotent stem cells, but there is limited, mostly correlational, information about these pluripotency-related miRNA in cancer. We evaluated whether aberrant expression of such miRNA could affect tumor cell behavior and stem-like traits, thereby contributing to the aggressiveness of medulloblastoma cells. Basal expression of primary and mature forms of miR-367 were detected in four human medulloblastoma cell lines and expression of the latter was found to be upregulated upon enforced expression of OCT4A. Transient overexpression of miR-367 significantly enhanced tumor features typically correlated with poor prognosis; namely, cell proliferation, 3-D tumor spheroid cell invasion and the ability to generate neurosphere-like structures enriched in CD133 expressing cells. A concurrent downregulation of the miR-367 cancer-related targets RYR3, ITGAV and RAB23, was also detected in miR-367-overexpressing cells. Overall, these findings support the pro-oncogenic activity of miR-367 in medulloblastoma and reveal a possible mechanism contributing to tumor aggressiveness, which could be further explored to improve patient stratification and treatment of this important type of pediatric brain cancer. (AU)

FAPESP's process: 11/10001-9 - Contribution of mesenchymal stem cells to tumor development
Grantee:Carolina de Oliveira Rodini
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 14/10519-6 - HIPPO SIGNALING PATHWAY AND ASYMMETRIC DIVISION OF CANCER STEM CELLS DERIVED FROM HUMAN MEDULLOBLASTOMA
Grantee:Beatriz de Araujo Cortez
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 13/17566-7 - Pluripotency factor OCT4A and aggressiveness of human medulloblastoma
Grantee:Patrícia Benites Gonçalves da Silva
Support type: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 10/52686-5 - E2F2 transcription factor and expression of proto-oncogenes in human embryonic stem cells
Grantee:Oswaldo Keith Okamoto
Support type: Regular Research Grants
FAPESP's process: 13/02983-1 - Expression of hsa-miR-367 and aggressiveness of human medulloblastoma
Grantee:Carolini Kaid Dávila
Support type: Scholarships in Brazil - Master
FAPESP's process: 13/08028-1 - CEGH-CEL - Human Genome and Stem Cell Research Center
Grantee:Mayana Zatz
Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC